Prossimo Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $879K | Sell |
1,975
-80
| -4% | -$35.6K | 0.71% | 36 |
|
|
2025
Q1 | $996K | Buy |
2,055
+6
| +0.3% | +$2.91K | 0.75% | 37 |
|
|
2024
Q4 | $825K | Sell |
2,049
-38
| -2% | -$15.3K | 0.6% | 47 |
|
|
2024
Q3 | $971K | Buy |
2,087
+459
| +28% | +$214K | 0.71% | 40 |
|
|
2024
Q2 | $763K | Buy |
1,628
+15
| +0.9% | +$7.03K | 0.69% | 43 |
|
|
2024
Q1 | $674K | Buy |
1,613
+125
| +8% | +$52.2K | 1.3% | 18 |
|
|
2023
Q4 | $605K | Buy |
1,488
+319
| +27% | +$130K | 1.28% | 26 |
|
|
2023
Q3 | $407K | Buy |
1,169
+140
| +14% | +$48.7K | 0.96% | 38 |
|
|
2023
Q2 | $362K | Buy |
1,029
+5
| +0.5% | +$1.76K | 0.35% | 92 |
|
|
2023
Q1 | $323K | Buy |
+1,024
| New | +$323K | 0.79% | 44 |
|